Vaccines 2012 World Market Analysis, Key Players, Trends, Pediatric and Adult Segments
Upcoming SlideShare
Loading in...5
×
 

Vaccines 2012 World Market Analysis, Key Players, Trends, Pediatric and Adult Segments

on

  • 461 views

 

Statistics

Views

Total Views
461
Views on SlideShare
461
Embed Views
0

Actions

Likes
0
Downloads
5
Comments
0

0 Embeds 0

No embeds

Accessibility

Categories

Upload Details

Uploaded via as Adobe PDF

Usage Rights

© All Rights Reserved

Report content

Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
  • Full Name Full Name Comment goes here.
    Are you sure you want to
    Your message goes here
    Processing…
Post Comment
Edit your comment

Vaccines 2012 World Market Analysis, Key Players, Trends, Pediatric and Adult Segments Vaccines 2012 World Market Analysis, Key Players, Trends, Pediatric and Adult Segments Document Transcript

  • Vaccines 2012 World Market Analysis, Key Players, Trends,Pediatric and Adult SegmentsReport Details:Published:September 2012No. of Pages: 249Price: Single User License – US$3995This report examines the market for vaccines used in humans to previous various types ofdisease. It covers only commercialized vaccines and developmental vaccines for diseases that arealready vaccine-preventable; it does not cover emerging vaccines for diseases that are notcurrently vaccine-preventable, such as Alzheimer’s disease, diabetes, Ebola infection, Epstein-Barr virus (EBV) infection, ETEC infection, heart attach, Helicobacter pylori infection, multiplesclerosis, Parkinson’s disease, West Nile virus (WNV) infection, etc.; vaccines that address theseand other not-yet-vaccine-preventable conditions are discussed in Kalorama’s new report, “WhatsNext in Vaccines.”The vaccine industry has seen changes in the past year, and these are covered in this reportVaccines 2012: World Market Analysis, Key Players, and Critical Trends in a Fast-ChangingIndustry. The high growth rates and successful launch of several products recently have keptinterest in the global vaccine market high. The global market for vaccines experienced stronggrowth through 2011 and this is expected to continue through the forecast period. Growth is beingfueled by new product introductions and rising usage in all regions.Included in this report are current market size and forecast for the following vaccines:Pediatric Vaccines:•Combinations•Hepatitis•HIB•MMR•Pneumococcal•Poliovirus•Varicella•Other PediatricAdult Vaccines:
  • •Cervical Cancer•Hepatitis•Influenza•Pneumococcal•Travel; DT; Misc.Kalorama has expanded the global perspective of this report in this edition, including estimates ofvaccine sales (pediatric and adult segments) in the following regions:•U.S.•Rest of North Amer.•South America•Europe•Japan•India•China•Rest of WorldDespite ongoing improvements in pediatric vaccination, it is estimated that at least two millionchildren die each year from diseases that could have been prevented by already existing vaccines.This problem is most significant in low income countries, with the health disparity between rich andpoor countries resulting in average life spans of about 77 and 52 years, respectively. In addition tothis high death toll, millions more suffer disability and illness because they have not beenimmunized. Adult immunization is an important, but frequently overlooked, part of patient care.Vaccination programs typically focus on children, yet adults in industrialized countries are morelikely to die as a result of vaccine-preventable diseases than are children.Key issues in the global vaccine market today include product safety, refusal to immunize, supplyshortages, the use of vaccines to prevent pandemics and address bioterrorism, and innovations invaccine delivery systems.The following issues are discussed in this report.•Vaccine Safety•Refusal to Immunize•Obesity•Post-Licensure Surveillance•The Future of Vaccine Safety•Vaccine Shortages•Preventing Pandemics•Project Bioshield Act•National Bio and Agro-Defense Facility•DNA Vaccination•Mucosal Delivery•Intranasal Delivery•Vaccine Patches•Vaccine Chips and Microneedles
  • •Innovations in Vaccine Production•Nanoparticle Systems•CloningVaccination protects not only individuals, but also entire communities from diseases spread byperson-to-person transmission.For example, vaccination can prevent about 50% of deaths frompneumococcal disease and 80% of deaths from influenza-related complications in the elderly.Pharmacoeconomic studies have demonstrated the value of influenza and pneumococcalvaccines; however, immunization rates for these diseases continue to be low in the elderlypopulations. This report includes profiles of the key players in vaccines, including:•AlphaVax, Inc.•Bavarian Nordic A/S•Baxter Healthcare•Bharat Biotech•Crucell /Johnson & Johnson•Emergent biosolutions•GlaxoSmithKline•Medimmune•Merck & Co. Inc•Novartis•Sanofi Pasteur•PfizerGet your copy of this report @http://www.reportsnreports.com/reports/195649-vaccines-2012-world-market-analysis-key-players-trends-pediatric-and-adult-segments.htmlMajor points covered in Table of Contents of this report includeTable Of ContentsExecutive SummaryTHE GLOBAL VACCINES INDUSTRYScope and MethodologyOverviewPediatric Preventative VaccinesTHE MARKETAdult Preventative VaccinesTHE MARKETTOTAL MARKETISSUES AND TRENDSIntroduction to VaccinesTHE IMMUNE RESPONSE
  • MECHANISM OF ACTION(Table) Impact of Vaccines in the 20th Century Annual Morbidity in the 20th Century vs 2011A BRIEF HISTORY: THE DEVELOPMENT OF VACCINESTYPES OF VACCINESAttenuated (Weakened) Live Viruses(Table) Vaccine-Preventable Diseases, August 2012Killed (Inactivated) VirusesToxoid VaccinesGenetically Engineered/Modified VaccinesVACCINE APPROVAL PROCESS(Table) VAERS Table of Reportable Events Following VaccinationPediatric Preventive VaccinesINTRODUCTION(Table) Global Immunization Rates by Vaccine Type 2010CHILDHOOD IMMUNIZATION IN THE UNITED STATES(Table) Immunization Profile of the United States: Population by Age Group, Number of Vaccine-Preventable Diseases Reported by Disease 1990 - 2010Childhood Immunization RatesChallenges to the Vaccine Delivery SystemThe Effect of U.S. Healthcare ReformRecommended Childhood Immunization Schedule(Table) U.S. Recommended Immunization Schedule for Children Ages 0 Through 6 Years, 2012(Table) U.S. Recommended Immunization Schedule for Adolescents Ages 7 to 18 Years, 2012State Immunization RecommendationsUnited Nations InitiativesPEDIATRIC VACCINE PRODUCTSBCGDiphtheria, Tetanus, Pertussis, Hepatitis B and PolioHaemophilus Influenzae Type BHepatitis AMeasles, Mumps and RubellaMeningococcal DiseasePneumococcal ConjugateRotavirusVaricellaPEDIATRIC VACCINES IN DEVELOPMENTCOST OF VACCINES IN THE UNITED STATES(Table) Selected Pediatric Vaccines in Development, August 2012THEWORLD MARKET FOR PEDIATRIC PREVENTIVE VACCINESTotal Market Size and Forecast(Table) World Market for Pediatric Vaccines by Type (DTaP/DTP, Hep, HiB, MMR, Combinations,
  • Pneumococcal, Polio, Varicella, Others) 2007-2016 Revenues (in millions)(Table) World Market for Pediatric Vaccines by Region (U.S., North America, South America, EU,Japan, India, China, Rest of World) 2006-2015 Revenues (in millions)Hepatitis Vaccine Market(Table) World Pediatric Hepatitis Vaccine Market 2007-2016Haemophilus Influenzae Type B Vaccine Market(Table) World Hib Vaccine Market, 2007-2016Measles, Mumps and Rubella Vaccines(Table) World MMR Vaccines Market 2007-2016Combination Vaccines Market(Table) World Combination Vaccines Market 2007-2016Pneumococcal Vaccine(Table) World Pediatric Pneumococcal Vaccine Market 2007-2016Poliovirus Vaccine(Table) World Poliovirus Vaccine Market 2007-2016Varicella Vaccines(Table) World Varicella Vaccine Market 2007-2016Other Vaccines Market(Table) World Pediatric Other Vaccines Market 2007-2016Adult Preventive VaccinesINTRODUCTIONADULT VACCINE-PREVENTABLE DISEASES: FACTS AND FIGURESGLOBAL INFLUENZA SURVEILLANCE PROGRAMU.S. SurveillanceRECOMMENDATIONS FOR ADULT IMMUNIZATIONS(Table) Universal Adult Immunization Schedule 2012(Table) Summary of Recommendations for Adult ImmunizationADULT VACCINE PRODUCTSCervical Cancer(Table) Initiatives to Require HPV Vaccination by U.S. State, 2012CholeraDiphtheria-TetanusHepatitisInfluenza(Table) WHO Pandemic Classification ScheduleJapanese EncephalitisPneumococcal DiseaseRabiesShinglesTyphoid FeverYellow Fever
  • ADULT VACCINES IN DEVELOPMENT(Table) Selected Adult Preventive Vaccines in Development, 2012THEWORLD MARKET FOR ADULT PREVENTIVE VACCINESTotal Market Size and Forecast(Table) World Market for Adult Preventive Vaccines by Type (Hepatitis, Influenza, Pneumococcal,Travel/DT/Misc.), 2007-2016 Revenues (in millions)(Table) World Market for Adult Vaccines by Region (U.S., North America, South America, EU,Japan, India, China, Rest of World) 2007-2016 Revenues (in millions)Cervical Cancer Market(Table) World Cervical CancerVaccine Market 2007-2016Hepatitis Market(Table) World Hepatitis Vaccine Market 2007-2016Influenza Vaccine Market(Table) World Influenza Vaccine Market 2007-2016(Table) 2011 Estimated Population by Region and Selected Age Group (in millions)(Table) World Pneumococcal Vaccine Market 2007-2016Travel, DT, and Miscellaneous Vaccine Market(Table) World Travel; Diphtheria-Tetanus; Miscellaneous Vaccines Market 2007-2016Vaccines Market SummaryTRENDS DRIVING THE VACCINES MARKETMARKET SIZE AND FORECAST(Table) The World Vaccines Market by Vaccine Type 2007-2016 Revenues (in millions)Vaccine Sales by RegionVaccine Market Competitors(Table) The World Vaccines Market by Region (U.S., North America, South America, EU, Japan,India, China, ROW) 2007-2016 Revenues in millions(Table) Major Manufacturers Shares of the World Vaccine Market, 2011Pediatric Vaccines(Table) Major Manufacturers Shares of the World Pediatric Vaccine Market 2011Adult Vaccines(Table) Major Manufacturers Shares of the World Adult Vaccine Market 2011Issues and TrendsVACCINE SAFETYRefusal to ImmunizeObesityPost-Licensure SurveillanceThe Vaccine Injury Compensation ProgramWorld Health OrganizationOther InitiativesThe Future of Vaccine Safety
  • VACCINE SHORTAGESPreventing Shortages in the Developed CountriesPreventing Shortages in Developing NationsPREVENTING PANDEMICSU.S. National Vaccine PlanVACCINES AND BIOTERRORISMOverviewProject Bioshield Act(Table) Selected Companies/Laboratories Developing Biodefense VaccinesNational Bio and Agro-Defense FacilityVaccine Treatment and Evaluation UnitsAnthraxSmallpoxDNA VACCINATIONINNOVATIONS IN VACCINE DELIVERY SYSTEMSMucosal DeliveryIntranasal DeliveryVaccine PatchesVaccine Chips and MicroneedlesINNOVATIONS IN VACCINE PRODUCTIONPlantsInsectsNanoparticle SystemsCloningCompany ProfilesALPHAVAX, INC.History and Lines of BusinessStrategic AlliancesVaccine ProductsFinancial InformationBAVARIAN NORDIC A/SHistory and Lines of BusinessStrategic AlliancesVaccine ProductsFinancial InformationBAXTER HEALTHCAREHistory and Lines of BusinessStrategic AlliancesVaccine ProductsFinancial InformationBHARAT BIOTECH
  • History and Lines of BusinessStrategic AlliancesVaccine ProductsFinancial InformationCRUCELL /JOHNSON &JOHNSONHistory and Lines of BusinessStrategic AlliancesVaccine ProductsFinancial InformationEMERGENT BIOSOLUTIONSHistory and Lines of BusinessStrategic AlliancesVaccine ProductsFinancialGLAXOSMITHKLINEHistory and Lines of BusinessStrategic AlliancesVaccine ProductsFinancial InformationMEDIMMUNEHistory and Lines of BusinessStrategic AlliancesVaccine ProductsFinancial InformationMERCK&CO. INCHistory and Lines of BusinessStrategic AlliancesVaccine ProductsFinancial InformationNOVARTISHistory and Lines of BusinessStrategic AlliancesVaccine ProductsFinancial InformationHistory and Lines of BusinessStrategic AlliancesVaccine ProductsFinancial InformationSANOFI PASTEURHistory and Lines of BusinessStrategic AlliancesVaccine Products
  • Financial InformationCompany DirectoryContact: sales@reportsandreports.com for more information.